Farmax India Ltd has informed BSE that the Board Meeting of the Company will be held on February 13, 2017, to consider and approve the following:<BR><BR>1. Unaudited Q3 results for the quarter ended December 31, 2016.<BR><BR>2. Limited Review report for the quarter ended December 31, 2016.<BR><BR>In this connection, the trading window shall remain closed for all the Directors / Officers / Designated employees / Promoters of the Company from day of February 02, 2017 till day of February 13, 2017 (both days inclusive).
|